Compare NVAX & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | CRI |
|---|---|---|
| Founded | 1987 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1995 | 2003 |
| Metric | NVAX | CRI |
|---|---|---|
| Price | $6.73 | $32.07 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 9 | 4 |
| Target Price | $10.78 | ★ $29.50 |
| AVG Volume (30 Days) | ★ 4.2M | 986.0K |
| Earning Date | 11-06-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 3.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.07 | ★ 2.45 |
| Revenue | $1,064,651,000.00 | ★ $2,832,687,000.00 |
| Revenue This Year | $58.91 | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $3.19 | $12.86 |
| Revenue Growth | ★ 20.27 | N/A |
| 52 Week Low | $5.01 | $23.38 |
| 52 Week High | $11.55 | $58.13 |
| Indicator | NVAX | CRI |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 54.81 |
| Support Level | $6.56 | $31.00 |
| Resistance Level | $7.03 | $32.44 |
| Average True Range (ATR) | 0.26 | 1.34 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 49.78 | 67.02 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.